OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Addex Therapeutics OCF Yield % Related Terms
Addex Therapeutics OCF Yield % Historical Data
* Premium members only.
The historical data trend for Addex Therapeutics's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:APE1 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, Addex Therapeutics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Addex Therapeutics OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Addex Therapeutics's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Addex Therapeutics's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Addex Therapeutics (STU:APE1) has a OCF Yield % of -34.03 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Addex Therapeutics and its competitors. According to the industry distribution chart, Addex Therapeutics ranks #1093 out of 1419 companies in the Biotechnology industry, placing it in the top 77%.
Is Addex Therapeutics' OCF Yield % too high?
Addex Therapeutics' current OCF Yield % is -34.03. Based on the distribution chart, Addex Therapeutics ranks #1093 out of 1419 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Addex Therapeutics has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Addex Therapeutics' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Addex Therapeutics ranks #1093 out of 1419 companies for OCF Yield %. This places Addex Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Addex Therapeutics and its competitors. Addex Therapeutics's current OCF Yield % is -34.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Addex Therapeutics stock overvalued right now?
Addex Therapeutics (STU:APE1) has a current OCF Yield % of -34.03. The stock's GF Value™ is €1.21, compared to a current price of €5.10 — trading 321.5% above its estimated fair value. The current OCF Yield % is -34.03. Addex Therapeutics' overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Addex Therapeutics (STU:APE1), the current OCF Yield % is -34.03 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Addex Therapeutics (STU:APE1) Overvalued in 2026?
Based on GuruFocus' analysis, Addex Therapeutics stock appears to be overvalued.
The current stock price of €5.10 is trading 321.5% above its estimated GF Value™ of €1.21.
Key valuation signals for STU:APE1:
OCF Yield %: -34.03
GF Value™: €1.21 vs. price of €5.10 (321.5% above fair value)
No single metric tells the full story. See the STU:APE1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
52GF Score
Get the complete analysis for STU:APE1
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:APE1 has been successfully added to your 
